4.6 Article

The Insulin-like Growth Factor-1 Binding Protein Acid-labile Subunit Alters Mesenchymal Stromal Cell Fate

Journal

JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 285, Issue 7, Pages 4709-4714

Publisher

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M109.041913

Keywords

-

Funding

  1. National Institutes of Health [AR054919, AR055141, AR045433, AR053853, AR054604]
  2. Charles H. Revson Foundation

Ask authors/readers for more resources

Age-related osteoporosis is accompanied by an increase in marrow adiposity and a reduction in serum insulin-like growth factor-1 (IGF-1) and the binding proteins that stabilize IGF-1. To determine the relationship between these proteins and bone marrow adiposity, we evaluated the adipogenic potential of marrow-derived mesenchymal stromal cells (MSCs) from mice with decreased serum IGF-1 due to knockdown of IGF-1 production by the liver or knock-out of the binding proteins. We employed 10-16-week-old, liver-specific IGF-1-deficient, IGFBP-3 knockout (BP3KO) and acid-labile subunit knock-out (ALSKO) mice. We found that expression of the late adipocyte differentiation marker peroxisome proliferator-activated receptor gamma was increased in marrow isolated from ALSKO mice. When induced with adipogenic media, MSC cultures from ALSKO mice revealed a significantly greater number of differentiated adipocytes compared with controls. MSCs from ALSKO mice also exhibited decreased alkaline-phosphatase positive colony size in cultures that were stimulated with osteoblast differentiation media. These osteoblast-like cells from ALSKO mice failed to induce osteoclastogenesis of control cells in co-culture assays, indicating that impairment of IGF-1 complex formation with ALS in bone marrow alters cell fate, leading to increased adipogenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

GH directly inhibits steatosis and liver injury in a sex-dependent and IGF1-independent manner

Andre Sarmento-Cabral, Mercedes del Rio-Moreno, Mari C. Vazquez-Borrego, Mariyah Mahmood, Elena Gutierrez-Casado, Natalie Pelke, Grace Guzman, Papasani Subbaiah, Jose Cordoba-Chacon, Shoshana Yakar, Rhonda D. Kineman

Summary: The study found that knocking down GHR in adult hepatocytes leads to non-alcoholic fatty liver disease, with no significant changes observed in female mice but with symptoms of steatosis, hepatocyte ballooning, and inflammation present in male mice.

JOURNAL OF ENDOCRINOLOGY (2021)

Article Cell Biology

Effects of GH/IGF axis on bone and cartilage

Manisha Dixit, Sher Bahadur Poudel, Shoshana Yakar

Summary: Growth hormone (GH) and insulin-like growth factor-1 (IGF-1) play crucial roles in regulating body growth and skeletal acquisition, with their activity declining with age and leading to detrimental effects on the musculoskeletal system.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2021)

Article Cell Biology

Sexual dimorphic impact of adult-onset somatopause on life span and age-induced osteoarthritis

Sher Bahadur Poudel, Manisha Dixit, Gozde Yildirim, Jose Cordoba-Chacon, Manuel D. Gahete, Ikeno Yuji, Thorsten Kirsch, Rhonda D. Kineman, Shoshana Yakar

Summary: The study found that adult-onset isolated GH deficiency can lead to increased severity of OA and extended lifespan in female mice. However, high levels of lymphomas were observed in both sexes with AOiGHD. Additionally, males with AOiGHD showed increased cell senescence and significantly decreased health span.

AGING CELL (2021)

Article Biology

Modeling bystander effects that cause growth delay of breast cancer xenografts in bone marrow of mice treated with radium-223

Didier A. Rajon, Brian S. Canter, Calvin N. Leung, Tom A. Back, J. Christopher Fritton, Edouard I. Azzam, Roger W. Howell

Summary: The study explored the importance of direct effects and bystander effects in cancer therapy with alpha-particle emitting radiopharmaceuticals using computational modeling and Monte Carlo radiation transport simulation. Results showed that a robust bystander effect component was necessary to simulate in vivo tumor proliferation, suggesting the need for more complex models to understand the full extent of (RaCl2)-Ra-223-induced bystander effects.

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2021)

Article Oncology

Radium-223-Induced Bystander Effects Cause DNA Damage and Apoptosis in Disseminated Tumor Cells in Bone Marrow

Brian S. Canter, Calvin N. Leung, J. Christopher Fritton, Tom Back, Didier Rajon, Edouard Azzam, Roger W. Howell

Summary: Radiation-induced bystander effects play a role in the cytotoxicity of DTC caused by (RaCl2)-Ra-223. Both irradiated and bystander MDA-MB-231 and MCF-7 cells showed DNA damage, with MDA-MB-231 bystander cells also exhibiting increased apoptosis in (RaCl2)-Ra-223-treated animals. Additionally, irradiated osteocytes displayed increased apoptosis as well.

MOLECULAR CANCER RESEARCH (2021)

Article Endocrinology & Metabolism

ZYG11A Is Expressed in Epithelial Ovarian Cancer and Correlates With Low Grade Disease

Laris Achlaug, Lina Somri-Gannam, Shilhav Meisel-Sharon, Rive Sarfstein, Manisha Dixit, Shoshana Yakar, Mordechai Hallak, Zvi Laron, Haim Werner, Ilan Bruchim

Summary: This study evaluated the expression of ZYG11A in EOC patients and found reduced ZYG11A expression in high grade tumors, suggesting a potential tumor suppressor role. The study also identified an inverse correlation between ZYG11A and p53 levels in individual tumors. Further exploration of ZYG11A as a novel biomarker in EOC is warranted based on these findings.

FRONTIERS IN ENDOCRINOLOGY (2021)

Article Cell Biology

The Olfactory Receptor Gene Product, OR5H2, Modulates Endometrial Cancer Cells Proliferation via Interaction with the IGF1 Signaling Pathway

Rand Shibel, Rive Sarfstein, Karthik Nagaraj, Lena Lapkina-Gendler, Zvi Laron, Manisha Dixit, Shoshana Yakar, Haim Werner

Summary: Endometrial cancer is commonly linked to the insulin-like growth factor-1 (IGF1) axis, while individuals with Laron syndrome (LS) are protected from cancer development due to IGF1 deficiency. The downregulation of OR5H2 gene in LS-derived cells suggests a potential role in endometrial cancer as a target for positive regulation by IGF1.

CELLS (2021)

Article Cell Biology

Induction of somatopause in adult mice compromises bone morphology and exacerbates bone loss during aging

Manisha Dixit, Silvana Duran-Ortiz, Godze Yildirim, Sher Bahadur Poudel, Leeann D. Louis, Andrzej Bartke, Mitchell B. Schaffler, John J. Kopchick, Shoshana Yakar

Summary: The study investigated the effects of induced somatopause on skeletal integrity using an iGHRKO mouse model, finding that induced somatopause resulted in thinner bones and compromised bone strength. There were progressive declines in osteocyte lacunar number and increases in lacunar volume, along with reductions in canalicular connectivity. Despite compromised bone morphology, osteocyte senescence was reduced in iGHRKO mice. Overall, induced somatopause compromised bone morphology and the bone marrow environment in aging mice.

AGING CELL (2021)

Article Cell Biology

Growth hormone receptor gene disruption in mature-adult mice improves male insulin sensitivity and extends female lifespan

Silvana Duran-Ortiz, Edward O. List, Yuji Ikeno, Jonathan Young, Reetobrata Basu, Stephen Bell, Todd McHugh, Kevin Funk, Samuel Mathes, Yanrong Qian, Prateek Kulkarni, Shoshana Yakar, Darlene E. Berryman, John J. Kopchick

Summary: Studies suggest that reducing growth hormone action can enhance healthy lifespan. In adult mice, disrupted GH action resulted in sexual dimorphic effects, with males showing enhanced insulin sensitivity and reduced tumors, while females exhibited increased lifespan and reduced glucose and oxidative stress.

AGING CELL (2021)

Article Endocrinology & Metabolism

Fsp27 plays a crucial role in muscle performance

Mark Slayton, Bijinu Balakrishnan, Abhishek Gupta, Scott Jobe, Ishika Puri, Savannah Neely, Yoshikazu Tamori, David W. Russ, Gozde Yildirim, Shoshana Yakar, Vishva M. Sharma, Vishwajeet Puri

Summary: This study identifies Fsp27 as a novel protein associated with muscle metabolism. The Fsp27-knockout model reveals that Fsp27 plays a role in muscular-fat storage, muscle endurance, and muscle strength, ultimately impacting limb movement. Additionally, the study suggests a potential metabolic paradox in which Fsp27-knockout mice, presumed to be metabolically healthy based on glucose utilization and oxidative metabolism, exhibit impaired exercise capacity and muscular performance.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2022)

Review Cell Biology

Pregnancy-Associated Plasma Protein (PAPP)-A2 in Physiology and Disease

Vicente Barrios, Julie A. Chowen, Alvaro Martin-Rivada, Santiago Guerra-Cantera, Jesus Pozo, Shoshana Yakar, Ron G. Rosenfeld, Luis A. Perez-Jurado, Juan Suarez, Jesus Argente

Summary: The GH/IGF axis is crucial in human growth, with recent research focusing on the role of the PAPP-A2 gene mutations in affecting physiology. Understanding the implications of PAPP-A2 can provide insights for controlling growth processes.

CELLS (2021)

Article Endocrinology & Metabolism

Lifelong Excess in GH Elicits Sexually Dimorphic Effects on Skeletal Morphology and Bone Mechanical Properties

Manisha Dixit, Leeann D. Louis, Jelena Basta-Pljakic, Gozde Yildirim, Sher-Bahadur Poudel, Fancy Kumararaja, Edward O. List, Silvana Ortiz Duran, John J. Kopchick, Ryan R. Ruff, Mitchell B. Schaffler, Shoshana Yakar

Summary: Excess in growth hormone levels can have different effects on bone depending on the gender. Male mice experience bone enlargement, marrow cavity expansion, and thin cortices, while female mice have smaller bone diameter but thicker cortices and better bone quality. Excess growth hormone also leads to increased bone remodeling. In conclusion, excess growth hormone results in sexually dimorphic changes in bone structure and mass.

JOURNAL OF BONE AND MINERAL RESEARCH (2022)

Article Pathology

Excess Growth Hormone Triggers Inflammation-Associated Arthropathy, Subchondral Bone Loss, and Arthralgia

Sher B. Poudel, Ryan R. Ruff, Gozde Yildirim, Manisha Dixit, Benoit Michot, Jennifer L. Gibbs, Silvana D. Ortiz, John J. Kopchick, Thorsten Kirsch, Shoshana Yakar

Summary: This study investigated the effects of long-term excess GH on the knee joint tissues. The results showed that excess GH leads to loss of articular cartilage, osteoporosis, synovitis, and chondrogenesis. The findings suggest that treatment of acromegalic arthropathy should involve inhibition of ectopic chondrogenesis and chondrocyte hypertrophy.

AMERICAN JOURNAL OF PATHOLOGY (2023)

Article Geriatrics & Gerontology

Long-term effects of canagliflozin treatment on the skeleton of aged UM-HET3 mice

Gozde Yildirim, Edmara T. P. Bergamo, Sher Bahadur Poudel, Ryan R. R. Ruff, Manisha Dixit, Bin Hu, Dindo Q. Q. Mijares, Lukasz Witek, Carolyn Chlebek, David E. E. Harrison, Randy Strong, Richard A. A. Miller, Warren Ladiges, Timothy G. G. Bromage, Clifford J. J. Rosen, Shoshana Yakar

Summary: SGLT2 inhibitors like CANA can reduce blood glucose levels, but long-term use may increase the risk of osteoporosis and cortical fractures.

GEROSCIENCE (2023)

Review Endocrinology & Metabolism

A systematic review and meta-analysis on the efficacy of stem cell therapy on bone brittleness in mouse models of osteogenesis imperfecta

Lauren Battle, Shoshana Yakar, Alessandra Carriero

Summary: Currently, there is no cure for osteogenesis imperfecta (OI) and stem cell therapy shows promise in reducing fractures in mouse models of OI. However, the efficacy of the therapy is influenced by various factors and further research is needed to establish standardized assessment criteria.

BONE REPORTS (2021)

No Data Available